Waltham-based BG Medicine Files for $86 Million IPO
From New England Tech Wire | Jan 29, 2010
Waltham, Mass. - BG Medicine, a Waltham-based life sciences company, has
filed with the Securities and Exchange Commission for its initial public
offering of stock to raise an estimated $86 million. The company was founded in
2000. Its lead product candidate is a test for heart failure. BG obtained CE
Mark in the European Union for a manual test in October 2009 and has begun
limited sales and marketing activities in certain countries in Europe. In March
2009, the company submitted premarket notification to the FDA in order to
obtain the regulatory clearance to market the test in the U.S.
http://www.sec.gov/Archives/edgar/data/1407038/000119312510016039/ds1.htm
____
_________________________________________
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| Be Self-Employed Writing Content | 0 | 0 | 292 | ||
| Work from Home Writing Articles | 0 | 0 | 120 | ||
| Band Together Seeks New Executive Director in Raleigh Area | 0 | 0 | 525 |